Show simple item record

dc.contributor.authorSenel, Tuba Elif
dc.contributor.authorUzun, Sami
dc.contributor.authorGurdal, Ahmet
dc.contributor.authorEroglu, Ayca
dc.contributor.authorOzturk, Savas
dc.contributor.authorKaradag, Serhat
dc.contributor.authorGÜRSU, Meltem
dc.contributor.authorCebeci, Egemen
dc.date.accessioned2021-03-05T17:05:30Z
dc.date.available2021-03-05T17:05:30Z
dc.date.issued2017
dc.identifier.citationUzun S., Karadag S., GÜRSU M., Cebeci E., Gurdal A., Senel T. E. , Eroglu A., Ozturk S., "Flow-Mediated Dilatation and Asymmetric Dimethylarginine Do Not Predict Mortality in Peritoneal Dialysis Patients", HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, cilt.55, ss.187-193, 2017
dc.identifier.othervv_1032021
dc.identifier.otherav_c3ccb6fd-7d96-4109-a461-c91e5ec50eb3
dc.identifier.urihttp://hdl.handle.net/20.500.12627/129906
dc.identifier.urihttps://doi.org/10.4274/haseki.10820
dc.description.abstractAim: Asymmetric dimethylarginine (ADMA) is associated with increased coronary artery disease risk through endothelial dysfunction in dialysis patients. We aimed to investigate the role of flow-mediated dilatation (FMD), a non-invasive indicator of endothelial function, and ADMA in mortality in peritoneal dialysis (PD) patients.
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.titleFlow-Mediated Dilatation and Asymmetric Dimethylarginine Do Not Predict Mortality in Peritoneal Dialysis Patients
dc.typeMakale
dc.relation.journalHASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI
dc.contributor.departmentIstanbul Haseki Training & Research Hospital , ,
dc.identifier.volume55
dc.identifier.issue3
dc.identifier.startpage187
dc.identifier.endpage193
dc.contributor.firstauthorID245514


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record